Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas
5/24/2013
| CHAPEL HILL, N.C. , May 24, 2013 Regulatory and marketplace changes have pushed Medical Affairs to the forefront of many organizations' priority list. Forward-thinking companies across the biopharmaceutical and medical device sectors understand a strong Medical Affairs function is essential to meeting current challenges in clinical development, market education , an... [Comments] |
BD to Present at the Deutsche Bank 38th Annual Health Care Conference
5/24/2013
| FRANKLIN LAKES, N.J. , May 24, 2013 BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today that it will present at the Deutsche Bank 38 th Annual Health Care Conference on Thursday, May 30, 2013, at 10:40 a.m. (ET). A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/... [Comments] |
Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg
5/24/2013
| BEVERLY HILLS, Calif. , May 24, 2013 /PRNewswire-iReach/ -- Phoenix Houses of California , the state's leading non-profit substance abuse services organization, is hosting its tenth annual "Triumph For Teens" Awards Gala at the Beverly Hills Hotel on June 6, 2013. More than 300 people are expected to attend the event to raise funds for the adolescent residential treatment centers, fa... [Comments] |
Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.
5/24/2013
| HAYWARD, Calif. , May 24, 2013 Solta Medical, Inc. (NASDAQ: SLTM ), a global leader in the medical aesthetics market, today reported Dr. Edward W. Knowlton has resigned as a member of the Company's Board of Directors effective immediately. Dr. Knowlton is the founder of Thermage, the predecessor company to Solta Medical and had served as a director since 1996. "O... [Comments] |
International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
5/24/2013
| LOS ANGELES , May 24, 2013 An international roster of experts on malignant pleural mesothelioma (MPM) gathered on Saturday, May 18, in Santa Monica, Calif. , to discuss their latest research findings on new lung-sparing therapies for MPM, a rare form of cancer that results from exposure to asbestos and commonly affects the pleura, the lining of the chest. Hosted by U... [Comments] |
Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference
5/24/2013
| LOVELAND, Colo. , May 24, 2013 Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today that Dr. Robert Grieve , the Company's chairman and chief executive officer, and Jason Napolitano , executive vice president and chief financial officer, will present at the Second Annual Marcu... [Comments] |
China Biologic Comments on the Proposed Shanghai RAAS Transaction
5/24/2013
| BEIJING , May 24, 2013 China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company has recently learned from a public announcement issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai RAAS"), a public company listed on Shenzhen... [Comments] |
Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference
5/24/2013
| CHESTERBROOK, Pa. , May 24, 2013 Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) today announced that executive management will participate in the Deutsche Bank Health Care Conference to be held May 29-30 at the Westin Boston Waterfront Hotel. Mr. Adrian Adams , Chief Executive Officer and President, is scheduled to present an overview of the Company and its pro... [Comments] |
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
5/24/2013
| NEW YORK , May 24, 2013 In accordance with Rule 17.1 and Rule 2.9 of the Irish Takeover Rules and Rule 14e-1 of the United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") today announced acceptance levels its original offer for Elan Corporation (NYSE: ELN). Background On 2 May 2013, Echo Pharma Acquisition Limited ("Royalty Pharma") made an offer fo... [Comments] |
Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines
5/24/2013
| BEIJING , May 24, 2013 Sinovac Biotech Ltd. (NASDAQ: SVA ), a leading provider of biopharmaceutical products in China , announced that Sinovac Beijing, the main operating subsidiary company of Sinovac, obtained the Certificate of Good Manufacturing Practices for Pharmaceutical Products (GMP Certificate) from the China State and Food Administration (CFDA) for its prop... [Comments] |
Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany
5/24/2013
| LONDON , May 24, 2013 The potential of the pulmonary route as a non-invasive administration for systemic delivery of therapeutic agents has been receiving undeniable attention with the recent advances of the inhalation drug delivery showing significant promise. The crucial formulation considerations for orally inhaled products together with those of a delivery device play a... [Comments] |